minitran 5 mg/24 timer
meda - asker - glyseroltrinitrat - depotplaster - 5 mg/24 timer
minitran 10 mg/24 timer
meda - asker - glyseroltrinitrat - depotplaster - 10 mg/24 timer
monoket od 25 mg
merus labs luxco ii s.à r.l. - isosorbidmononitrat - depotkapsel, hard - 25 mg
monoket od 50 mg
merus labs luxco ii s.à r.l. - isosorbidmononitrat - depotkapsel, hard - 50 mg
monoket od 100 mg
merus labs luxco ii s.à r.l. - isosorbidmononitrat - depotkapsel, hard - 100 mg
symtuza
janssen-cilag international nv - darunavir, cobicistat, emtricitabine, tenofovir alafenamide - hiv-infeksjoner - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - symtuza er indisert for behandling av infeksjon av human immunodeficiency virus type 1 (hiv-1) hos voksne og ungdom (i alderen 12 år og eldre med kroppsvekt minst 40 kg). genotypic testing should guide the use of symtuza.
darunavir accord 800 mg
accord healthcare b.v. - darunavirpropylenglykolat - tablett, filmdrasjert - 800 mg
darunavir accord 600 mg
accord healthcare b.v. - darunavirpropylenglykolat - tablett, filmdrasjert - 600 mg
dutasteride/tamsulosin hexal 0.5 mg / 0.4 mg
hexal a/s - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.